{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-033360","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2026-07-15T20:15:43+00:00","discovered_at":"2026-07-15T20:17:00.482963+00:00","generated_at":"2026-07-15T20:17:05.332877+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ensysce Biosciences COO Jeffrey Millard resigns effective July 10, 2026","bullets":["Jeffrey Millard resigned as Chief Operating Officer on July 10, 2026.","Resignation notice received and effective on the same date.","No replacement or interim COO has been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-033360","json":"https://secwatch.observer/filing/0001493152-26-033360.json","markdown":"https://secwatch.observer/filing/0001493152-26-033360.md","text":"https://secwatch.observer/filing/0001493152-26-033360.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226033360/0001493152-26-033360-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226033360/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-15T20:17:05.332877+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}